Spring Course

Practicing gastroenterologists, gastrointestinal endoscopists and surgeons, GI fellows, and GI nurses and associates
 

The Spring Course is devoted to a review of the most compelling topics discussed during Digestive Disease Week® 2020. Faculty will present critically important information on new drugs, the etiology and pathophysiology of disease states, the epidemiology of diseases, the medical, surgical and endoscopic treatment of disease, and the social impact of disease states pertaining to gastroenterology, endoscopy, and liver disease. 

The program includes a video forum of new endoscopic techniques as well as a summary of the major topics presented at the most important academic forum in gastroenterology, making for an invaluable educational experience for those who were unable to attend Digestive Disease Week® and an excellent summary review for those who were there.
 

Learning Objectives

• Discuss the spectrum of commonly seen disorders of the esophagus and stomach, such as gastroesophageal reflux disease, Barrett’s esophagus, and motility disorders, and outline related treatment options and their effectiveness
• Evaluate advances in the methods of assessing disease status in patients with inflammatory bowel disease, and discuss the application of these techniques to patient treatment
• Discuss the efficacy and safety of treatments for viral hepatitis, nonalcoholic fatty liver disease, and other chronic liver disorders
• Identify appropriate methods to detect and treat common disorders of the small bowel and colon, such as colon polyps, as well as endobariatric therapy for obesity, and review the effectiveness of these approaches
• Examine the diagnostic and therapeutic capabilities of current and emerging advanced endoscopic techniques, to diagnose and treat disorders of the hepatobiliary tract, pancreas, and luminal gastrointestinal tract and to detect and manage obscure upper and lower GI bleeding
   

8:15 am - 9:00 am
Registration and Continental Breakfast

 

9:00 am
Welcome 

Pari Shah, MD, MS and Arun Swaminath, MD 

Franklin E. Kasmin, MD

 

9:00 am – 9:20 am
Esophageal Motility Disorders

9:20 am – 9:40 am
GERD and Barrett’s Esophagus

9:40 am – 10:00 am
Functional Bowel Disease 

10:00 am – 10:20 am
Non-IBD Small Bowel Disease

10:20 am – 10:50 am
Break 

 

10:50 am – 11:10 am
Colon Cancer and Polyps

11:10 am – 11:30 am
Inflammatory Bowel Disease

11:30 am – 12:00 pm
Highlights of the 2020 ASGE Video Plenary Session I

12:00 pm – 1:00 pm
Lunch Break   

    

1:00 pm – 1:20 pm
GI Bleeding

1:20 pm – 1:40 pm
Endoscopic Treatment of Obesity 

1:40 pm – 2:00 pm
Biliary Tract Disease

 

2:00 pm – 2:20 pm
Pancreatic Disease

2:20 pm – 2:50 pm
Break 

 

2:50 pm – 3:10 pm
Viral Hepatitis

3:10 pm – 3:30 pm
Nonalcoholic Fatty Liver Disease and Other Liver Disorders 

3:30 pm – 3:50 pm
Highlights of the 2020 ASGE Video Plenary Session II

3:50 pm – 4:00 pm
Wrap-Up and Final Questions
 

Franklin E. Kasmin, MD, NYSGEF Clinical Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai; Medical Director, The Pancreas and Biliary Center, Mount Sinai Beth Israel, New York, NY

 

Pari Shah, MD, MS Assistant Professor of Clinical Medicine, Weill Cornell Medical College; Gastroenterology, Hepatology and Nutrition Service, Memorial Sloan Kettering Cancer Center, New York, NY

 

Arun Swaminath, MD Associate Professor of Medicine, Hofstra Northwell School of Medicine; Director, IBD Program, Lenox Hill Hospital–Northwell Health, New York, NY
 

Albert Einstein College of Medicine requires that faculty participating in a CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
 
Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved in the United States.
 

 

Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine-Montefiore Medical Center requires that faculty participating in any CME activity disclose to the audience any relationship(s) with commercial interest; pharmaceutical or equipment company*. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device, not yet approved in the United States.

*The ACCME defines a Commercial Interest as an entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interest – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.
 

This continuing nursing education activity has been submitted to the Northeast Multi-State Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Maine, New Hampshire, New York, Rhode Island, Vermont Nurses Associations are members of the Northeast Multi-State Division of the American Nurses Association.

This educational activity has been submitted to the Certification Board for Sterile Processing and Distribution, Inc. (CBSPD) for continuing education credit toward maintenance of certification.
 

The facilities used for NYSGE seminars are in full compliance with provisions of the Americans with Disabilities Act (ADA) and are accessible for individuals with special needs. If you would like to attend this conference and require any special accommodations, please contact the NYSGE Office at 646-218-0650.
 

From time-to-time, NYSGE takes photographs or video during educational courses and events and reproduces them in educational, informational or promotional materials including print, electronic or other media such as the NYSGE website. By participating in this course, you grant NYSGE the right to use your name and photograph for such purposes and all such postings become the property of NYSGE.